文/水博

 

几天以前，看到《31位国际学术同仁声援肖传国医生的公开信》，我曾经写了一封《给支持肖传国的国际同仁们的公开信》的博文，表达了我对这些写信挺肖的外国医生们的困惑、震惊和愤怒。我觉得，面对肖传国犯罪的事实，这些外国医生在公开信中所说的话，简直就像是一群无耻的小丑。

 

警方分明已经查明肖传国是一个背地里雇人行凶的刑事罪犯，而他们还非要发表公开信宣布说“肖医生是一个极富同情心的绅士”，难道他们的同情心就是要用锤子去杀人吗？此外，这个肖传国在雇人行凶之后，还要卑鄙的大肆散布并向警方举报被害人报假案，故意无耻的欺骗警方和社会公众。然而，当这样一个狡猾、阴险的罪犯被中国警方侦破落网之后，居然还有一些所谓的国际同行，跑出来用公开信证明肖传国的诚实。

 

这些外国同仁们在公开信中，不仅为肖传国的人品作伪证，而且还公开表示对肖的犯罪“难以置信”，同时还要求保障肖传国的基本人权。请问，这是什么意思?把这两点连起来看，这不就是在公开的怀疑和诬蔑中国警方拘捕刑事罪犯的行为吗？按照他们的公开信的意思来看，似乎肖传国不可能是一个刑事犯罪，而是受到了某种迫害。

 

根据公开信中的这些违法的内容，我当时就怀疑支持肖传国的公开信的签名者肯定是被欺骗了。他们极可能不懂中文，所签名的公开信或许是别人翻译后给他们看的，具体英文是怎么翻译的，或者动员他签名的人又是怎么解释的就很难说了。如果动员他们签名的人，如实的告诉他们，肖传国因犯罪已经被警方拘捕，并且本人已经承认雇凶犯罪事实的话，他们是绝不可能故意写一封“涉嫌做伪证”的公开信来挑战中国的司法。

 

果不其然，还没等我把揭露他们做伪证、干预中国司法的公开信寄给他们，这些写信的国际同行们已经发现，自己曾经签名的公开信具有被欺骗的错误内容。不仅涉嫌做伪证，而且已经严重的干涉中国的刑事司法。所以，他们马上修改了这封信中，关于肖传国人品的伪证部分，和对中国司法的干涉内容。

 

例如，原来的公开信中说“国际科学界对肖医生被拘捕的消息感到震惊。我们这些了解肖医生的人，都对他涉入此案感到难以置信。 肖医生是一个极富同情心的绅士，他的诚实和对本学科作出的开创性的科学成就广受世界同行的尊敬。我们恳请中国政府和有关权威机构公正对待肖大夫，并在案情调查期间保障他的基本人权。”

 

而更改后的公开信已经比较客观，只强调了他们对肖传国的学术看法，而不再对肖传国的人品作任何虚假的评价。相关内容改为说“我们有幸结识传传国医生多年。他是国际公认的外科医生、科学家，他对神经再生，恢复排尿和排便功能的发展有重要的贡献。肖医生在美国进行了开创性的动物研究，证明了一个运动神经支配的腿是可以用来膀胱和肠道。这将允许再支配的反射启动膀胱功能的开发。他的研究结果已经发表在同行审阅的专业期刊上，其他科学家也正在复制和调查、证实肖医生的这些结果。”

 

看到这先后大不相同的公开信，有的网友愤怒的说“这些外国医生也够无耻脸的，先是写了一封虚假的欺骗信，被人揭发后，又要耍赖，修改掉最关键的部分”。

 

我认为事实不可能是这样。这些人应该都是有较好的素养医生，绝不会无缘无故的拿自己的声誉去为一个罪犯做伪证。我认为他们所签名的第一封信，肯定是被肖传国的同伙欺骗了。而当发现自己已经被骗之后为了弥补被动、尴尬的局面，不得不又重发了一封意思比较准确的公开信。否则，他们何必非要在一个有待于证实的科研课题问题上，为一个刑事罪犯罪分子去趟浑水呢？

 

我这么说绝对是有根据的。其实他们写信给中国的官方说明“肖氏反射弧”的科学、有效性，不仅没有太多的实际意义，而且，也是非常的愚蠢。首先，他们所强调的内容基本上没有意义，因为在中国行肖传国的这项研究也是国家级的973重要研究课题。其次，肖传国目前所遇到的麻烦，完全不是在于“肖氏反射弧”是否科学、有效，而是在于他为了敛财，欺骗公众，故意夸大还不成熟的手术效果，骗取了大量的患者，在不知情的情况下成为了他的人体试验品。致使很多花费了大量钱财的患者，不仅治疗无效，而且很多人还因为他的非法手术而致残。

 

在这种情况下，肖传国的同行们如果真的敢认定“肖氏反射弧”的科学有效性。他们要真想帮助肖传国，根本就不用给中国官员写信说明什么，只要公开宣布说，所有要状告肖传国手术失败的患者，都可以到他们那里重新接受手术。不就万事大吉了吗？

 

他们现在之所以只敢写公开信给中国官员，强调他们对“肖氏反射弧”的看法，足以说明他们对“肖氏反射弧”的科学有效性也仅仅是持一种赞同的态度，而还没有任何治疗成功的把握。

 

然而，为什么一些世界知名的医生却要在明知“肖氏反射弧”不是成熟的医疗手段的情况下，还非要向中国官员强调一个尚未确定的科研课题的观点和态度呢？我想恐怕不会是出自他们对“肖氏反射弧”的前景的坚定的信任，而很可能是由于他们曾经受到肖传国的同伙欺骗，已经发出了一封“涉嫌伪证和干预中国司法”的公开信。为了挽回这种做伪证的影响，除了公开揭发肖传国的欺骗之外，他们只能用一封新的公开信，来为自己体面的解脱。

 

如果谁认为我说得不对，你们可以给其中的任何一位医生去信询问。问他敢不敢把肖传国做手术失败的那些患者接过去。用手术可以成功的事实，证明“肖氏反射弧”的科学和有效？我敢断言，他们中间没有一个人会答应。

 

因为，他们很清楚“肖氏反射弧”的治疗效果是否有效，目前还是一个尚未解决的世界级难题。因此，我国的官员和公众，应该体谅外国医生们被欺骗后又不想得罪肖传国的懊恼，大可不必对他们的公开信过于挑剔、认真。更不要过分的谴责、批评他们。如果要谴责，大家应该谴责起草为肖传国做伪证的公开信的始作俑者和中国国内造假团伙的卑鄙和无耻。

 

附：最初支持肖传国的国际同仁们的公开信的原文参见：

http://www.sciencenet.cn/m/user_content.aspx?id=368620

说明：看来肖传国的势力真是了得。目前几乎所有网站都已经把国外医生那封涉嫌做伪证的公开信换成了新版的。不过我这里还有截屏下来的证据。可以让大家看看：

 

更改后公开信：

http://www.sciencenet.cn/m/user_content.aspx?id=369386

 

Open letter in support of Chuan-Guo Xiao, M.D. from the International Academic Community

September 29, 2010

Mr. Zhu Chen, Minister
Ministry of Health
People’s Republic of China

Mr. Peigen Li, President
Huazhong University of Science and Technology
People’s Republic of China

Minister Chen and President Li:

We have all had the pleasure of knowing Dr. Chuan-Guo Xiao for many years. He is an internationally respected surgeon-scientist who has made major advances in the development of neuroregeneration to restore voiding and bowel function.  Dr. Xiao performed groundbreaking animal research in the United States, demonstrating that a motor nerve that innervates the leg can be used to reinnervate the bladder and bowel.  This reinnervation allows for development of a reflex to initiate bladder function.   The results of his studies were published in peer-reviewed journals and other scientists have replicated Xiao’s findings confirming these results.

Dr. Xiao eventually took the courageous step of moving from animal research to human studies and began performing the rerouting procedure on patients with spinal cord injury and spina bifida in China. Neurogenic bladder is life threatening in China due to a lack of both antimuscarinics and intermittent catheterization and lessening the complications of neurogenic bladder would be considered a lifesaving success.  Patients with neurogenic bladder and bowel suffer greatly and endure a host of issues such as urinary retention, incontinence, recurrent infections, renal insufficiency, fecal incontinence, constipation,and poor quality of life.  For a procedure as complicated as nerve rerouting requiring nerve regeneration, one cannot expect normalization of bladder and bowel function to be the definition of success.  What is
important is that the benefits outweigh the risks of the procedure.

Dr. Xiao published his clinical results in peer-reviewed journals and was twice honored by the Jack Lapides Essay Contest - one of the most respected international awards given to scientists who make major contributions to the field of neurourology.  In 2008 he was named the Kelm Hjalmas Memorial Lecturer from the International Children’s Continence Society for his scientific achievements.  Many of us have traveled to China to examine patients treated by Dr. Xiao and/or have been trained by him in the nerve rerouting surgery he invented.  Dr. Xiao is a very skilled surgeon who is passionate about patient care and works tirelessly to train physicians around the world in performing his nerve rerouting procedure.

In the United States, an independent and very rigorous pilot research trial was performed to test the safety and efficacy of this procedure.  The one-year results were recently published in the Journal of Urology.  At the 12-month follow-up visit, a cutaneous to bladder reflex was found in 7 of 9 spina bifida patients, confirming that rerouting does occur.  This finding by itself is remarkable and Dr. Xiao should be commended.  In addition, a number of patients demonstrated improvement in bladder and bowel function, which has continued to improve with longer patient follow-up. The 36-month results are currently being analyzed and will be reported in the near future.  The pilot data was supportive of Dr. Xiao’s procedure and now an NIH sponsored clinical trial is being conducted to further study lumbar to sacral nerve rerouting in spina bifida patients.  In addition, similar procedures have been done worldwide with Dr. Xiao helping to mentor the surgeons at each site.
 
The Chinese people and government should be proud of Dr. Xiao for his dedication to his patients, his scientific achievements, and his willingness to train doctors around the world on how to perform his surgery. The international scientific community was shocked to hear of Dr. Xiao’s arrest.  Those of us who know Dr. Xiao well find it difficult to believe that he is involved in these attacks.

Dr. Xiao is a compassionate man who is respected worldwide for his integrity and his innovative scientific contributions to society.  We implore the Chinese government and authorities to treat Dr. Xiao fairly and to protect his human rights as these charges are investigated.  Please strongly consider Dr. Xiao’s scientific and humanitarian contributions to the world as facts are gathered in this case.

Sincerely,

 
Kenneth M. Peters, M.D.
Professor and Chairman of Urology
Beaumont Hospital
Royal Oak, Michigan  USA

Jack S. Elder, M.D.
Chief of Urology, Henry Ford Health System Associate Director, Vattikuti Urology Institute Dept of Urology,

Children's Hospital of Michigan
Clinical Professor of Urology, Case School of
Medicine
Detroit, Michigan  USA

Edwin A. Smith, M.D.
Assistant Clinical Professor of Urology Emory University School of Medicine Atlanta, Georgia  USA

Kevin M. Feber, M.D., FAAP Beaumont Children's Hospital Royal Oak, Michigan  USA

Ananias C. Diokno, M.D., F.A.C.S. Executive Vice President & CMO Beaumont Hospital
Royal Oak, Michigan 48073 USA

Juan José de Benito, M.D. Urologist
Hospital Nacional de Clínicas
Córdoba, Argentina

William E. Nantau B.Sc., CNIM Clinical Manager
Clinical Neurophysiology Department
Beaumont Hospital
Royal Oak, MI USA

Evan J Kass,  M.D., FACS,.FAAP Chief, Division of Pediatric Urology Beaumont Childrens Hospital
Professor of Urology, Oakland University
William Beaumont School of Medicine
Royal Oak, MI USA
 
Jacques Corcos,  M.D.
Professor of Urology, McGill University General Secretary of the International Continence Society
Jewish General Hospital
3755 Cote Ste-Catherine
Montreal, Quebec, Canada  H3T 1E2

Jose Gonzalez, M.D. Department of Urology Beaumont Hospital
Royal Oak, Michigan  USA

Christopher Payne, M.D. Associate Professor of Urology Stanford University Medical School Stanford, CA  94305-5118 

USA

Kenneth I. Glassberg, M.D.
Director, Division of Pediatric Urology Morgan Stanley Children's Hospital of New York-Presbyterian
Professor of Urology, Columbia University
College of Physicians and Surgeons
3959 Broadway, CHN 1118
New York, NY  USA

Earl Y. Cheng, M.D.
Associate Professor of Urology Children’s Memorial Hospital Chicago, Illinois USA

Darius J. Bagli, MDCM Professor of Surgery Senior Associate Scientist
Director of Urology Research
Divisions of Urology and Developmental & Stem Cell Biology The Hospital For Sick Children Institute of Medical

Science University of Toronto
 
Henri B. LOTTMANN, M.D., FEBU, FEBPS, FRCS(england) FEBPU
Paediatric Urology Unit
Hopital Necker-Enfants-Malades
149, rue de Sèvres
75015   Paris, France

Dr. Amrish Vaidya MS. MCh. Consultant Paediatric Surgeon, Kokilaben Dhirubhai Ambani Hospital,
4 Bungalows, Andheri W, Mumbai, India

Marc Cendron, M.D.
Associate Professor in Urology Harvard Medical School Children’s Hospital Boston Boston, MA  USA

Stuart B. Bauer, M.D.
Associate Director, Neurourology
Professor of Urology Harvard Medical School Children’s Hospital Boston Boston, MA USA

Edmond T. Gonzales, Jr., M.D. Professor of Urology
Baylor College of Medicine
Houston, TX USA

Richard Macchia, M.D. FACS
SUNY Distinguished Teaching Professor
Cleveland Clinic, Florida USA

Benjamin Girdler, M.D. Urology Center of the Rockies Fort Collins, Colorado  USA

William C. de Groat, Ph.D. Professor of Pharmacology University of Pittsburgh Pittsburgh, PA  USA

Michael R. Ruggieri, Sr., Ph.D. Director of Urologic Research
Temple University School of Medicine
Philadelphia, PA  USA

Stanley J Kogan, M.D. Chief, Pediatric Urology Children's Hospital at Montefiore Bronx, NY USA

Anthony Caldamone, M.D. University Urologic Associates, Inc.
2 Dudley St Ste 185
Providence, RI 02905 USA
 
Yves Homsy M.D., FRCSC, FAAP
Clinical Professor of Urological Surgery and
Pediatrics
University of South Florida
Children's Urology Group
5507 E. Longboat Blvd
Tampa FL 33615  USA

Dr. Enrique Turina
Professor of Urology of the National University of Buenos Aires
Chief of Section Urology of Instituto de
Rehabilitación
Government of Buenos Aires, Argentina

Dr. Angel Ozón
Urologist of the Instituto de Rehabilitación of
Buenos Aires
Government of Buenos Aires, Argentina

Dr. Daniel Ekizian
Urologist of Instituto de Rehabilitación. Government of Buenos Aires, Argentina

Professor Dr. med. Karl-Dietrich Sievert
Vice Chair
Prof. of Urology, Director - Uro-oncology, Neurourology, Incontinence, & Reconstructive Urology
Department of Urology University of Tuebingen
D72076 Tuebingen, Germany

Holly Gilmer, M.D.
Chief of Pediatric Neurosurgery
Beaumont Hospital
Royal Oak, Michigan USA

Yegappan Lakshmanan, M.D. Chief, Pediatric Urology Children’s Hospital of Michigan Detroit, MI USA

Fábio V C Sparapani, M.D., PHD Escola Paulista de Medicina-
Federal University of São Paulo, Brasil

David B. Joseph, M.D. Professor of Surgery
Chief of Pediatric Urology UAB School of Medicine Birmingham, Alabama  USA

 

转载本文请联系原作者获取授权，同时请注明本文来自张博庭科学网博客。
链接地址：https://blog.sciencenet.cn/blog-295826-369688.html

上一篇：对国际同行支持肖传国的公开信的质疑和分析
下一篇：给31位支持肖传国的外国医生的公开信（修改稿）